SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study

Sodium-glucose cotransporter 2 (SGLT2) inhibition is recognized for its evident renoprotective benefits in diabetic renal disease. Recent data suggest that SGLT2 inhibition also slows down kidney disease progr...

Source: Lipids in Health and Disease - March 20, 2024 Category: Lipidology Authors: Zhijuan Wang, Jie Wei, Wenman Zhao, Rui Shi, Yuyu Zhu, Xunliang Li and Deguang Wang Tags: Research Source Type: research